SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Claud B who wrote (350)5/29/1997 9:26:00 PM
From: Bruce Rosen   of 7041
 
Hi Claud. I wouldn't be surprised if there were an article in the main, national pages of the WSJ. This whole area of impotence has been receiving a great deal of attention recently. I would think that an in depth article, describing all of the options available and being worked on, would be of great benefit to all WSJ readers.

I noted your response to the comparison of Zonagen to Pixar. I agree with you that Zonagen will receive a sum of money as part of an agreement with a major, international drug company. I believe the news released this week makes such an agreement far more likely than it previously was. Are there any educated opinions out there as to how such a deal would be structured; upfront money, milestone payments, royalties, anything else? What amount of up front money would be reasonable from the perspective of a major drug company?

Thanks in advance for any replies.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News